Vikram Thermo (India) Limited

vikramthermo.com

Vikram Thermo (India) Limited is dedicated to discovery, development, manufacturing and marketing of research based life influencing products. Company has dedicated force to reckon with catalyst of need driven innovation and agent of change in pharmaceutical, chemical and cosmetic industries.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

HEMOGENYX PHARMACEUTICALS AND SELEXIS SA WILL ADVANCE HEMOGENYX’S ACUTE MYELOID LEUKEMIA (AML) CDX BISPECIFIC ANTIBODY TO HUMAN TRIALS

Hemogenyx Pharmaceuticals plc | January 13, 2022

news image

Hemogenyx Pharmaceuticals plc the biopharmaceutical group developing new therapies and treatments for blood diseases, and Selexis SA, a JSR Life Sciences company, have signed a service agreement to develop the cell line for Hemogenyx’s CDX bispecific antibody for the treatment of acute myeloid leukemia (AML). Under the agreement, Hemogenyx will leverage Selexis’ proprietary SUREtechnology Platform™, a suite of cell line development tools and technologies that significantly redu...

Read More

Research

DARWINHEALTH ANNOUNCES SCIENTIFIC COLLABORATION WITH PRELUDE THERAPEUTICS IN ONCOLOGY

Prelude Therapeutics | October 13, 2021

news image

DarwinHealth, Inc. today announced a scientific research collaboration that uses its Biomarker Enrichment Strategies for Assays (BEST platform ) to elucidate novel biomarkers that guide translational trajectories of multiple cancer molecules being developed by Prelude Therapeutics. Under the collaboration, DarwinHealth will use its proprietary, quantitative, systems biology-based algorithms, CLIA-approved technologies, and validated approaches focused on Protein Master Regulator (...

Read More

Pharma Tech

NOVOTECH AND MEDIDATA EXPAND PARTNERSHIP TO CONTINUE ADVANCEMENTS IN CLINICAL RESEARCH

Medidata | June 16, 2022

news image

Medidata, a Dassault Systèmes company, announced its renewed, expanded partnership with Novotech, a leading contract research organisation to continue scaling clinical studies in various therapeutic areas from 2022. Leveraging Rave EDC, Rave RTSM, eCOA and eConsent technology from Medidata, Novotech is equipped with flexible, configurable tools that can address clinical research needs at scale and facilitate accelerated drug and device development in Asia Pacific and the U....

Read More

ARGENX LIGHTS UP BRIDGES, TEASES DOCUMENTARY IN MYASTHENIA GRAVIS AWARENESS PUSH

Fiercepharma | June 08, 2020

news image

Argenx is launching its first awareness efforts for autoimmune disease myasthenia gravis. The campaign began recently with a virtual conference, light-up nights around the country, a patient website debut and the promise of an upcoming documentary. The kickoff event on June 1, which was also the first day of MG Awareness Month, was a virtual meeting of physician and patient speakers along with the first MG Illuminate night that lit up the Zakim Bridge in Boston in the color teal. Throughout the ...

Read More
news image

Research

HEMOGENYX PHARMACEUTICALS AND SELEXIS SA WILL ADVANCE HEMOGENYX’S ACUTE MYELOID LEUKEMIA (AML) CDX BISPECIFIC ANTIBODY TO HUMAN TRIALS

Hemogenyx Pharmaceuticals plc | January 13, 2022

Hemogenyx Pharmaceuticals plc the biopharmaceutical group developing new therapies and treatments for blood diseases, and Selexis SA, a JSR Life Sciences company, have signed a service agreement to develop the cell line for Hemogenyx’s CDX bispecific antibody for the treatment of acute myeloid leukemia (AML). Under the agreement, Hemogenyx will leverage Selexis’ proprietary SUREtechnology Platform™, a suite of cell line development tools and technologies that significantly redu...

Read More
news image

Research

DARWINHEALTH ANNOUNCES SCIENTIFIC COLLABORATION WITH PRELUDE THERAPEUTICS IN ONCOLOGY

Prelude Therapeutics | October 13, 2021

DarwinHealth, Inc. today announced a scientific research collaboration that uses its Biomarker Enrichment Strategies for Assays (BEST platform ) to elucidate novel biomarkers that guide translational trajectories of multiple cancer molecules being developed by Prelude Therapeutics. Under the collaboration, DarwinHealth will use its proprietary, quantitative, systems biology-based algorithms, CLIA-approved technologies, and validated approaches focused on Protein Master Regulator (...

Read More
news image

Pharma Tech

NOVOTECH AND MEDIDATA EXPAND PARTNERSHIP TO CONTINUE ADVANCEMENTS IN CLINICAL RESEARCH

Medidata | June 16, 2022

Medidata, a Dassault Systèmes company, announced its renewed, expanded partnership with Novotech, a leading contract research organisation to continue scaling clinical studies in various therapeutic areas from 2022. Leveraging Rave EDC, Rave RTSM, eCOA and eConsent technology from Medidata, Novotech is equipped with flexible, configurable tools that can address clinical research needs at scale and facilitate accelerated drug and device development in Asia Pacific and the U....

Read More
news image

ARGENX LIGHTS UP BRIDGES, TEASES DOCUMENTARY IN MYASTHENIA GRAVIS AWARENESS PUSH

Fiercepharma | June 08, 2020

Argenx is launching its first awareness efforts for autoimmune disease myasthenia gravis. The campaign began recently with a virtual conference, light-up nights around the country, a patient website debut and the promise of an upcoming documentary. The kickoff event on June 1, which was also the first day of MG Awareness Month, was a virtual meeting of physician and patient speakers along with the first MG Illuminate night that lit up the Zakim Bridge in Boston in the color teal. Throughout the ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us